These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11738536)

  • 21. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers.
    Cannon TD; Zorrilla LE; Shtasel D; Gur RE; Gur RC; Marco EJ; Moberg P; Price RA
    Arch Gen Psychiatry; 1994 Aug; 51(8):651-61. PubMed ID: 8042914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.
    Kertzman S; Reznik I; Grinspan H; Weizman A; Kotler M
    Isr J Psychiatry Relat Sci; 2008; 45(2):114-20. PubMed ID: 18982837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
    Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
    Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive factors in schizophrenia: causes, impact, and treatment.
    Meltzer HY
    CNS Spectr; 2004 Oct; 9(10 Suppl 11):15-24. PubMed ID: 15475873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
    Kahn JP
    Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia--progressive and massive decline in response readiness by episodes.
    Levander S; Jensen J; Gråwe R; Tuninger E
    Acta Psychiatr Scand Suppl; 2001; (408):65-74. PubMed ID: 11730075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.
    Rollnik JD; Borsutzky M; Huber TJ; Mogk H; Seifert J; Emrich HM; Schneider U
    Neuropsychobiology; 2002; 45(2):74-80. PubMed ID: 11893863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.
    Minzenberg MJ; Poole JH; Benton C; Vinogradov S
    Am J Psychiatry; 2004 Jan; 161(1):116-24. PubMed ID: 14702259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of neuroleptic-resistant schizophrenic relapse.
    Kinon BJ; Kane JM; Johns C; Perovich R; Ismi M; Koreen A; Weiden P
    Psychopharmacol Bull; 1993; 29(2):309-14. PubMed ID: 7904762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
    Schuepbach D; Hill SK; Sanders RD; Hell D; Keshavan MS; Sweeney JA
    Schizophr Bull; 2004; 30(4):837-48. PubMed ID: 15957199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients.
    Fujii DE; Ahmed I; Jokumsen M; Compton JM
    J Neuropsychiatry Clin Neurosci; 1997; 9(2):240-5. PubMed ID: 9144103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia.
    Matsui M; Sumiyoshi T; Kato K; Yoneyama E; Kurachi M
    Psychol Rep; 2004 Apr; 94(2):387-97. PubMed ID: 15154161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.
    Hill SK; Schuepbach D; Herbener ES; Keshavan MS; Sweeney JA
    Schizophr Res; 2004 May; 68(1):49-63. PubMed ID: 15037339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia and memory impairment: evidence for a neurocognitive subtype.
    McDermid Vaz SA; Heinrichs RW
    Psychiatry Res; 2002 Dec; 113(1-2):93-105. PubMed ID: 12467949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns and clinical correlates of neuropsychologic deficits in patients with schizophrenia.
    Liu SK; Hsieh MH; Huang TJ; Liu CM; Liu CC; Hua MS; Chen WJ; Hwu HG
    J Formos Med Assoc; 2006 Dec; 105(12):978-91. PubMed ID: 17185240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    Meltzer HY; McGurk SR
    Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?
    Albus M; Hubmann W; Mohr F; Scherer J; Sobizack N; Franz U; Hecht S; Borrmann M; Wahlheim C
    Schizophr Res; 1997 Nov; 28(1):39-50. PubMed ID: 9428063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
    Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
    Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.